Comparison between Ultrasound guided External Oblique Intercostal Plane Block and Thoracic Erector Spinae block for Post Thoracotomy Pain - Trial PACTR202302491451057
Access comprehensive clinical trial information for PACTR202302491451057 through Pure Global AI's free database. This Phase 4 trial is sponsored by Dr Saad moharam and is currently Recruiting. The study focuses on Surgery; Anaesthesia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Dr Saad moharam
Principal investigator
Timeline & Enrollment
Phase 4
Nov 08, 2022
Jan 01, 1900
Summary
This prospective double-blinded randomized study will be conducted to evaluate the analgesic efficacy of Ultrasound-guided External Oblique Intercostal Plane Block (EOIB) versus The analgesia provided by erector spinal block after Thoracotomy incision and possible complications in both groups. This prospective double-blinded randomized study will be carried out in Tanta University Hospitals in the Cardiothoracic Surgery Department for 6 months from November 2022 to April 2023 on 60 patients of both genders scheduled for thoracic surgery operated through open thoracotomy incision.Study duration: 6 months from November 2022 to April 2023 Inclusion criteria:Patients scheduled for Thoracic surgery aged between 21- 65 years of both genders, and have ASA I and II.Exclusion criteria:Patient refusal, presence of Infection at the injection site and patients with a history of allergy to local anaesthetics.60 patients will be equally divided to two equal groups (30 patients for each group)Group 1: Ultrasound-guided External Oblique Intercostal Plane Block Group 2: Ultrasound-guided Erector Spinae Block (ESB) Block will be performed after General anaesthesia induction using the same anaesthetic mixture (30 ml plain bupivacaine 0.25%) injected at the level of the 5th rib in the post-axillary line. - the following will be measured:- 1- Demographic data as (age, sex, Weight, BMI, indication and duration of surgery). 2- Hemodynamic Parameters: mean arterial blood pressure, and heart rate (MAP & HR) will be recorded before block performance at T0 after surgery at T (0, 6, 12, 18, 24 hours) where T0 = before discharge from PACU.3- Total opioid consumption (morphine) at the first 24 h after surgery.4- Numeric Rating scale (NRS): NRS will be assessed after surgery over 24 hours during rest and with cough 5- Time to first rescue analgesic requirement after surgery 6- Adverse events as Pneumothorax, and local Anaesthetic systemic toxicity.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202302491451057
Non-Device Trial